Abscess formation mimicking disease progression, in a patient with metastatic renal cell carcinoma during sunitinib treatment
<p>Abstract</p> <p>Background</p> <p>Renal cell carcinoma (RCC) represents approximately 3% of all adult cancers and is more common in males. Systemic treatment for RCC has improved following the introduction of tyrosine kinase inhibitors, such as sunitinib. The molecul...
Main Authors: | Gennatas Constantine, Kondi-Pafiti Agathi, Arkadopoulos Nikolaos, Michalaki Vasiliki |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | World Journal of Surgical Oncology |
Online Access: | http://www.wjso.com/content/8/1/45 |
Similar Items
-
Chromophobe renal cell carcinoma with prolonged response to targeted therapy: a case report
by: Michalaki Vasiliki, et al.
Published: (2012-04-01) -
Successful treatment with the mTOR inhibitor everolimus in a patient with Perivascular epithelioid cell tumor
by: Gennatas Constantine, et al.
Published: (2012-09-01) -
Sunitinib in the treatment of metastatic renal cell carcinoma
by: Thomas A. Schmid, et al.
Published: (2016-12-01) -
The role of sunitinib in the therapy of metastatic renal cell carcinoma
by: I. G. Rusakov, et al.
Published: (2020-07-01) -
Experience with sunitinib in the treatment of metastatic renal cell carcinoma
by: Manuela Schmidinger, et al.
Published: (2012-10-01)